Factor VII Deficient – Depleted Plasma
Affinity’s Factor VII Deficient – Depleted Plasma is manufactured from pooled normal human plasma depleted of Factor VII using antibodies directed to Factor VII. Only the highest quality citrated plasma is used as starting material. Our Deficient Plasma products are typically buffered with the addition of HEPES to 20mM final concentration.
This Factor VII Deficient – Depleted Plasma (FVII-DP) from Affinity Biologicals is available for Research Use Only and must not be used for diagnostic applications.
Factor VII Deficient Plasma
Factor VII Deficient Plasma is manufactured from normal citrated human plasma that has been depleted of Factor VII by selective affinity immuno-adsorption using antibodies directed towards FVII.
Only the highest quality citrated plasma is used as starting material and in many cases the parent plasma is available as control material. Plasma products are typically buffered with the addition of HEPES to 20mM final concentration and are available in 1ml vials to litre quantities. Our Factor VII deficient plasma can be used for further manufacturing or research use only applications.
Product Code: FVII-DP
Presentation: Frozen Factor VII Deficient Plasma
Preparation/Handling: Thaw 1 ml vials in 37oC water bath for 5 minutes; for bulk volumes, thawing time will be dependent on bottle size.
Storage and Stability: Plasma is shipped frozen and should be stored below -60oC. Product is stable until date stated on vial label when stored at -60oC. Once thawed, plasma is stable for 4 hours at 2-8oC in original vial.
Certificate of Analysis: available upon request
Description of Factor VII
Factor VII (FVII, also known as Stable Factor and Proconvertin) is a vitamin K-dependent glycoprotein produced in the liver. Plasma concentration of FVII is normally ~0.5 μg/ml (10 nM) in plasma. A deficiency of FVII is associated with bleeding in a clinical pattern similar to haemophilia, but is inherited as an autosomal recessive trait. The deficiency can be characterized by a quantitative (low activity and low antigen) or a qualitative (low activity and normal antigen) defect in FVII function. In its zymogen form FVII is a single chain molecule of ~50 kDa. It contains two EGF-like domains and an amino-terminal domain containing 10 γ-carboxyglutamic acid (Gla) residues. These Gla residues allow FVII to bind divalent metal ions and participate in calcium-dependent binding interactions. FVII and activated FVII (FVIIa) bind to tissue factor exposed at the site of vascular injury. FIXa, FXa or FVIIa rapidly activate tissue factor-bound FVII to FVIIa in the presence of calcium and phospholipid. Thrombin and FXIIa are able to activate FVII in the fluid phase in the absence of cofactors. The activation of the single chain zymogen FVII occurs by proteolysis after residue Arg152, resulting in a two-chain active serine protease consisting of a 30 kDa heavy chain and a 18 kDa light chain. In complex with tissue factor, phospholipid and calcium, FVIIa is able to activate F.X and F.IX. Free FVIIa in plasma is remarkably stable, but the activity of FVIIa/TF complex is regulated by Tissue Factor Pathway Inhibitor (TFPI) in the presence of F.Xa, and also by Antithrombin (ATIII) in the presence of heparin1-3.
References and Reviews
- Rao LVM, Bajaj SP, Rapaport SI; Activation of Human Factor VII During Clotting in Vitro; Blood 65, pp 218-226, 1985.
- Lawson, JH, Butenas S, Ribarik N, Mann KG; Complex-dependent Inhibition of Factor VIIa by Antithrombin III and Heparin; JBC 268 pp 767-770, 1993.
- Nemerson Y, in Hemostasis and Thrombosis, 3rd Edition, eds. RW Colman, J Hirsh, VJ Marder and EW Salzman, pp. 81-93, J.B. Lippincott Co., Philadelphia PA, USA, 1994.
INH7-DP – Frozen Factor VII Inhibitor Plasma – 1ml and bulk
INH7-LDP – Lyophilized Factor VII Inhibitor Plasma – 1ml
SAFVII-HRP – Sheep anti human Factor VII, peroxidase conjugated IgG (0.2 mg vial)
FRDP070105 – VisuDep-F Frozen Factor VII deficient plasma – 5 x 1ml Box (IVD)
FRDP070125 – VisuDep-F Frozen Factor VII deficient plasma – 25 x 1ml Box (IVD)
SAFVII-APFTC – Sheep anti human Factor VII, affinity purified, FITC conjugated IgG (0.1 mg vial)
SAFVII-APBIO – Sheep anti human Factor VII, affinity purified, Biotinylated IgG (0.1 mg vial)
FVII-DP – Factor VII Deficient Plasma – 1ml or bulk quantities
SAFVII-AP – Sheep anti human Factor VII, affinity purified IgG (0.5 mg vial)
FVII-AG – Complete Factor VII Antigen ELISA Kit – 1 plate/kit
FVII-EIA – Factor VII Paired Antibody Set – 5 plate set
SAFVII-IG – Sheep anti human Factor VII, purified IgG (10mg vial)